{"id":685153,"date":"2022-09-14T08:34:18","date_gmt":"2022-09-14T12:34:18","guid":{"rendered":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/"},"modified":"2022-09-14T08:34:18","modified_gmt":"2022-09-14T12:34:18","slug":"reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference","status":"publish","type":"post","link":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/","title":{"rendered":"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference"},"content":{"rendered":"<div class=\"mw_release\">\n<p align=\"justify\">SAN CLEMENTE, Calif., Sept.  14, 2022  (GLOBE NEWSWIRE) &#8212; <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=RV_DWevtYZNB204m3vLNMjpXKFWO5Nu4tJHWJiIurhdyvYZUiZV9ACJU_rX7SJleidLI25b9_UvsWUjW5tX2ypTbK_tY36nt-CGNaal6pNo=\" rel=\"nofollow noopener\" target=\"_blank\"><strong>ReShape Lifesciences<\/strong><\/a><strong>\u2122 (Nasdaq: RSLS), <\/strong>the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer and Tom Stankovich, Chief Financial Officer, will be participating in one-on-one meetings with institutional investors during the A.G.P. Virtual MedTech Conference, taking place Thursday, September 21, 2022.<\/p>\n<p align=\"justify\">Investors participating in the virtual conference who are interested in meeting with ReShape\u2019s management team should contact their A.G.P. representative.<\/p>\n<p align=\"justify\">\n        <strong>About ReShape Lifesciences\u2122<\/strong><br \/>\n        <br \/>ReShape Lifesciences\u2122 is America&#8217;s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band\u00ae Program provides minimally invasive, long-term treatment of obesity and is an alternative to more invasive surgical stapling procedures such as the gastric bypass or sleeve gastrectomy. Reshape<strong>care<\/strong>\u2122 is a virtual weight-management program that supports lifestyle changes for all weight-loss patients led by board certified health coaches to help them keep the weight off over time. The recently launched ReShape Marketplace\u2122 is an online collection of quality wellness products curated for all consumers to help them achieve their health goals. The ReShape Vest\u2122 System is an investigational (outside the U.S.) minimally invasive, laparoscopically implanted medical device that wraps around the stomach, emulating the gastric volume reduction effect of conventional weight-loss surgery. It helps enable rapid weight loss in obese and morbidly obese patients without permanently changing patient anatomy. For more information, please visit <a href=\"https:\/\/www.globenewswire.com\/Tracker?data=F8ZlBc2dA8Xrd-Jm0v-25r0DPUdEfFYXi3v6A4DuX0RwB6lKdSJkk5dB9OWP4NXbcwdFRu96wTqXkKI8QKU0Nn3BHQv9Qyt-_UqUty6yC61bz9KcWThVyegutwaq9MKa\" rel=\"nofollow noopener\" target=\"_blank\">www.reshapelifesciences.com<\/a>,<\/p>\n<p>\n        <strong>CONTACTS<\/strong><br \/>\n        <br \/>\n        <strong>ReShape Lifesciences Investor Contact:<\/strong><br \/>\n        <br \/>Thomas Stankovich<br \/>Chief Financial Officer<br \/>949-276-6042<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=NSToVGP0XKiy7qGeuObnSFJtaOhNM2Hz-Gow-5qd2a5s8u7r_UemZW1e5df3qrTEpB2X5VSdfR7YfwpVLMfAilfkXL-4bC0SDirigOnl5vU=\" rel=\"nofollow noopener\" target=\"_blank\">ir@ReShapeLifesci.com<\/a><\/p>\n<p align=\"justify\">\n        <strong>Investor Relations Contact:<\/strong><br \/>\n        <br \/>Rx Communications Group<br \/>Michael Miller<br \/>(917)-633-6086<br \/><a href=\"https:\/\/www.globenewswire.com\/Tracker?data=0ICVzAcqGoxXWXB8y-1cJNjDw0jpLOY_2T8dZYIQPQRVwQM6enD3fDk74xlTm0lTeskq1eF_NnzLw9wWl_aOQg==\" rel=\"nofollow noopener\" target=\"_blank\">mmiller@rxir.com <\/a><\/p>\n<\/p>\n<p>      <img decoding=\"async\" class=\"__GNW8366DE3E__IMG\" src=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI=\" \/><br \/>\n      <br \/>\n      <img decoding=\"async\" src=\"https:\/\/ml.globenewswire.com\/media\/MTE1M2I0NDAtMTc3NC00Y2I3LThmNGEtNWVhNmYwOGNhNmJkLTEwMTg2NDU=\/tiny\/ReShape-Lifesciences-Inc.png\" \/>\n    <\/div>\n<div class=\"mw_contactinfo\"><\/div>\n","protected":false},"excerpt":{"rendered":"<p>SAN CLEMENTE, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences\u2122 (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer and Tom Stankovich, Chief Financial Officer, will be participating in one-on-one meetings with institutional investors during the A.G.P. Virtual MedTech Conference, taking place Thursday, September 21, 2022. Investors participating in the virtual conference who are interested in meeting with ReShape\u2019s management team should contact their A.G.P. representative. About ReShape Lifesciences\u2122 ReShape Lifesciences\u2122 is America&#8217;s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band\u00ae Program provides minimally invasive, long-term &hellip; <\/p>\n<p class=\"link-more\"><a href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/\" class=\"more-link\">Continue reading<span class=\"screen-reader-text\"> &#8220;ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference&#8221;<\/span><\/a><\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[],"tags":[],"class_list":["post-685153","post","type-post","status-publish","format-standard","hentry"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference - Market Newsdesk<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference - Market Newsdesk\" \/>\n<meta property=\"og:description\" content=\"SAN CLEMENTE, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences\u2122 (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer and Tom Stankovich, Chief Financial Officer, will be participating in one-on-one meetings with institutional investors during the A.G.P. Virtual MedTech Conference, taking place Thursday, September 21, 2022. Investors participating in the virtual conference who are interested in meeting with ReShape\u2019s management team should contact their A.G.P. representative. About ReShape Lifesciences\u2122 ReShape Lifesciences\u2122 is America&#8217;s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band\u00ae Program provides minimally invasive, long-term &hellip; Continue reading &quot;ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference&quot;\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/\" \/>\n<meta property=\"og:site_name\" content=\"Market Newsdesk\" \/>\n<meta property=\"article:published_time\" content=\"2022-09-14T12:34:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI=\" \/>\n<meta name=\"author\" content=\"Newsdesk\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Newsdesk\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"1 minute\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/\"},\"author\":{\"name\":\"Newsdesk\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"headline\":\"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference\",\"datePublished\":\"2022-09-14T12:34:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/\"},\"wordCount\":290,\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI=\",\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/\",\"name\":\"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference - Market Newsdesk\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI=\",\"datePublished\":\"2022-09-14T12:34:18+00:00\",\"author\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\"},\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI=\",\"contentUrl\":\"https:\\\/\\\/www.globenewswire.com\\\/newsroom\\\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI=\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#website\",\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/\",\"name\":\"Market Newsdesk\",\"description\":\"Latest Business News in Real Time\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/#\\\/schema\\\/person\\\/482f27a394d4fda80ecb5499e519d979\",\"name\":\"Newsdesk\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g\",\"caption\":\"Newsdesk\"},\"url\":\"https:\\\/\\\/www.marketnewsdesk.com\\\/index.php\\\/author\\\/newsdesk\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference - Market Newsdesk","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/","og_locale":"en_US","og_type":"article","og_title":"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference - Market Newsdesk","og_description":"SAN CLEMENTE, Calif., Sept. 14, 2022 (GLOBE NEWSWIRE) &#8212; ReShape Lifesciences\u2122 (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Paul F. Hickey, President and Chief Executive Officer and Tom Stankovich, Chief Financial Officer, will be participating in one-on-one meetings with institutional investors during the A.G.P. Virtual MedTech Conference, taking place Thursday, September 21, 2022. Investors participating in the virtual conference who are interested in meeting with ReShape\u2019s management team should contact their A.G.P. representative. About ReShape Lifesciences\u2122 ReShape Lifesciences\u2122 is America&#8217;s premier weight loss and metabolic health-solutions company, offering an integrated portfolio of proven products and services that manage and treat obesity and metabolic disease. The FDA-approved Lap-Band\u00ae Program provides minimally invasive, long-term &hellip; Continue reading \"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference\"","og_url":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/","og_site_name":"Market Newsdesk","article_published_time":"2022-09-14T12:34:18+00:00","og_image":[{"url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI=","type":"","width":"","height":""}],"author":"Newsdesk","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Newsdesk","Est. reading time":"1 minute"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/#article","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/"},"author":{"name":"Newsdesk","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"headline":"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference","datePublished":"2022-09-14T12:34:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/"},"wordCount":290,"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI=","inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/","url":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/","name":"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference - Market Newsdesk","isPartOf":{"@id":"https:\/\/www.marketnewsdesk.com\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/#primaryimage"},"image":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/#primaryimage"},"thumbnailUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI=","datePublished":"2022-09-14T12:34:18+00:00","author":{"@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979"},"breadcrumb":{"@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/#primaryimage","url":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI=","contentUrl":"https:\/\/www.globenewswire.com\/newsroom\/ti?nf=ODY0NjE2MyM1MTUxNjE4IzIwMDcwNzI="},{"@type":"BreadcrumbList","@id":"https:\/\/www.marketnewsdesk.com\/index.php\/reshape-lifesciences-announces-participation-in-the-a-g-p-virtual-medtech-conference\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.marketnewsdesk.com\/"},{"@type":"ListItem","position":2,"name":"ReShape Lifesciences Announces Participation in the A.G.P Virtual MedTech Conference"}]},{"@type":"WebSite","@id":"https:\/\/www.marketnewsdesk.com\/#website","url":"https:\/\/www.marketnewsdesk.com\/","name":"Market Newsdesk","description":"Latest Business News in Real Time","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.marketnewsdesk.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/www.marketnewsdesk.com\/#\/schema\/person\/482f27a394d4fda80ecb5499e519d979","name":"Newsdesk","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/a0d0bd5b0f0ca12a265a459b13169dac35f33776d8501eda5e68844a366f2f46?s=96&d=mm&r=g","caption":"Newsdesk"},"url":"https:\/\/www.marketnewsdesk.com\/index.php\/author\/newsdesk\/"}]}},"_links":{"self":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/685153","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/comments?post=685153"}],"version-history":[{"count":0,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/posts\/685153\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/media?parent=685153"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/categories?post=685153"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.marketnewsdesk.com\/index.php\/wp-json\/wp\/v2\/tags?post=685153"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}